Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
pharmaphorum
NOVEMBER 1, 2023
Imfinzi faces Keytruda competition in biliary tract cancer Phil.Taylor Wed, 01/11/2023 - 18:27 Bookmark this
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 4, 2023
to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.
European Pharmaceutical Review
OCTOBER 14, 2022
Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years. Seven more are expected to be launched in 2023. A rise in savings per quarter was recognised in this year’s data.
Fierce Pharma
OCTOBER 2, 2023
Even as Biogen weighs strategic options for its biosimilars unit, the group is celebrating an industry first. | The exact launch timing of the biosimilar remains unclear, but Roche said it expects competition to kick off in the second half of 2023.
Pharmaceutical Technology
JANUARY 25, 2023
Despite this, Spikevax’s average annual sales forecast has plummeted by 23% between H1 and H2 2022 according to GlobalData’s Coronavirus Disease 2019 (COVID-19) Sector Forecast reports, due to increasing competition from Pfizer’s Comirnaty, Novavax’s Nuvaxovid, and Covid-19 therapeutics.
Healthcare Success
DECEMBER 6, 2022
In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Competition from Retail and Telehealth Disruptors Continues to Intensif y. Focus on these key audiences to stay competitive: a.
European Pharmaceutical Review
AUGUST 21, 2023
For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1
pharmaphorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
Contrarian Sales Techniques
DECEMBER 31, 2023
Reflecting on 2023 2023 has been a year like no other. Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations. The Power of Adaptability : If there's one thing 2023 has taught us, it's the importance of adaptability in sales.
PM360
SEPTEMBER 21, 2023
Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.
LEVO Health
JANUARY 31, 2023
Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan. Keywords that are too general will lead to more competition and a less targeted audience.
Clarivate
DECEMBER 19, 2022
For 2023 Medicare Advantage open enrollment, the United States’ largest retailer will begin a 10-year partnership with the nation’s largest insurer. The partnership dovetails with Walmart Health’s plans for 15 new Florida clinics across the Jacksonville, Orlando and Tampa markets by the end of 2023. MA national enrollment.
Clarify Health
JUNE 29, 2023
Ideon will power Clarify Networks’ competitive intelligence software module with national insurance network data across commercial, Affordable Care Act (ACA), and Medicare Advantage (MA) markets to empower health plans to gain valuable insights into their competitors’ networks.
Fierce Pharma
JULY 11, 2023
With Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely. With Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely.
PM360
APRIL 25, 2023
Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. The increase, from ASP plus 6% to ASP plus 8%, will last for five years, and may help increase access to and utilization of biosimilars and promote competition in the marketplace.
European Pharmaceutical Review
JANUARY 10, 2023
Clarivate Plc has released its Drugs to Watch 2023 report — among 70 of the drugs highlighted, including potential blockbuster drugs, the majority were revealed to be personalised medicines. The report offers predictive analysis of drugs entering the market or launching key indications in 2023. Drug development in 2023 and beyond.
Clarify Health
NOVEMBER 15, 2021
By 2023, available annual profit pools will range from $11 billion to $13 billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers ¹. For one national health plan, the strategy to improve and expand their Medicare Advantage networks was built upon meeting competitive overlap targets.
Clarify Health
JANUARY 23, 2024
from 2023 to 2032 , highlighting a growing demand in today’s business landscape—but also underscoring the need for TPAs in healthcare to distinguish themselves from competitors to attract clients and ensure their ongoing success. The TPA market is expected to grow at a compound annual growth rate of 9.6%
pharmaphorum
AUGUST 17, 2022
The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The post UK life science competitiveness indicators 2022: measuring what matters most?
LEVO Health
DECEMBER 20, 2022
As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. Adopting the following six marketing strategies may help you stay competitive, bring in new patients, and grow your practice substantially. 6 Medical Marketing Strategies to Adopt in 2023.
Clarivate
DECEMBER 18, 2023
As 2023 comes to a close , make sure you don’t miss out on the timely insights from Clarivate , created to help IP legal teams plan for the rapidly changing industry. As IP legal teams strategically navigated 2023 Clarivate created resources to help, backed by insights from industry experts.
Copyright Clearance Center
MAY 16, 2023
May 16, 2023 – Danvers, Mass. – Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries. Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries.
Star OUTiCO
NOVEMBER 30, 2022
January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Reassess ahead of 2023. The post Top tips for finding a new job in 2023 appeared first on Star OUTiCO.
Pharmaceutical Technology
MAY 11, 2023
The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Centers for Disease Control and Prevention had the most mentions of internet of things in Q1 2023. Buy the report here.
Pharmaceutical Technology
MAY 29, 2023
The global pharmaceutical industry experienced a 17% rise in company filings mentions of blockchain in Q1 2023 compared with the previous quarter, with the highest share accounted for by Bayer, according to GlobalData’s analysis of over 60 pharmaceutical company filings. The overall index for blockchain in Q1 2023 was 74.
Pharmaceutical Technology
JUNE 12, 2023
The global pharmaceutical industry experienced a 120% rise in company filings mentions of internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for by Moderna, according to GlobalData’s analysis of over 61 pharmaceutical company filings. The overall index for internet of things in Q1 2023 was 77.
European Pharmaceutical Review
NOVEMBER 30, 2023
Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.
European Pharmaceutical Review
APRIL 11, 2024
percent CAGR between 2023 and 2032. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. The latter of which is important in “gaining a competitive advantage”, the author noted. million by 2032, at 17.6
Eversana Intouch
JANUARY 19, 2023
Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. – is changing, and has big implications for the competitive marketplace. Pharma marketers in 2023 need to: Look for blind spots. or technology, too?
Pharmaceutical Technology
MAY 16, 2023
More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61 trillion in Q4 2022 to $3.49 million by 2029.
European Pharmaceutical Review
JANUARY 11, 2024
billion, so biosimilar competition could significantly expand patient access to this biologic therapy within the fields of gastroenterology, dermatology, and rheumatology, according to STADA and Alvotech. The EU ustekinumab market is worth €2.5 In this region, STADA already has six biosimilars approved in this market.
Pharma Marketing Network
APRIL 5, 2023
Attending the Reuters Pharma Marketing 2023 event on March 28-29 was a fascinating experience as the pharma marketing industry continues to return to in-person events. The post Reuters Pharma USA 2023 Recap appeared first on Pharma Marketing Network. Congratulations to the Reuters team on a great job, well executed!
Healthcare Success
NOVEMBER 7, 2022
They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.
pharmaphorum
JANUARY 27, 2023
It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. In any case, there is only so much that companies can do on their own – which brings us to the third likely trend for 2023. The impact is two-fold.
Clarify Health
AUGUST 8, 2023
This is the third inclusion of Clarify Health in a Gartner report in 2023. San Francisco, CA (August 8, 2023) – Clarify Health , a leading healthcare analytics and value-based payments platform company, today announced its inclusion in the Gartner Hype Cycle for U.S. In the Hype Cycle for U.S.
PM360
APRIL 7, 2023
However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Expect the nine competitors to explore Kotler’s 4Ps of Marketing to gain share in this lucrative and competitive marketplace.
Copyright Clearance Center
MARCH 15, 2023
Other companies on the 2023 KMWorld list include Accenture, Adobe, AWS, Deloitte, Google, IBM, Microsoft, Oracle, and Salesforce. Customer conversations about content users’ experiences continue to guide us as we develop solutions to transform information into insight,” said Tracey Armstrong, President and CEO, CCC.
MedReps
JANUARY 30, 2023
If you know how to prepare and get ahead of your competition, reaching your goals will be that much easier. Medical Sales Trends to Watch Out For in 2023 If you want to know what the future holds and create some forward-thinking sales goals, then check out these medical sales trends to watch out for in 2023.
Clarivate
DECEMBER 6, 2022
In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.
European Pharmaceutical Review
NOVEMBER 30, 2023
The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5
Pharmaceutical Technology
NOVEMBER 7, 2023
At BIO-Europe 2023, experts said competition from the US and China and proposed European legislation are hurdles for this sector.
Clarify Health
NOVEMBER 15, 2021
By 2023, available annual profit pools will range from $11 billion to $13 billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers¹. Medicare Advantage is expected to reach 40% penetration by 2025.
Quantified
JANUARY 3, 2023
This will be a competitive issue in the next 12 months. The media will achieve peak AI hype in 2023 A day won’t go by where some journalist isn’t discovering that #gpt3 can write an article for them (I’m already bored of it). The post What Will Happen with AI in 2023 appeared first on Quantified AI.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content